Brokers Set Expectations for UnitedHealth Group Inc’s Q1 2017 Earnings (UNH)

UnitedHealth Group Inc (NYSE:UNH) – Analysts at Leerink Swann dropped their Q1 2017 earnings per share (EPS) estimates for UnitedHealth Group in a research note issued to investors on Monday, Zacks Investment Research reports. Leerink Swann analyst A. Gupte now expects that the healthcare conglomerate will post earnings of $2.19 per share for the quarter, down from their previous forecast of $2.20. Leerink Swann currently has a “Hold” rating and a $210.00 target price on the stock. Leerink Swann also issued estimates for UnitedHealth Group’s Q2 2017 earnings at $2.33 EPS, Q3 2017 earnings at $2.57 EPS and Q4 2017 earnings at $2.40 EPS.

UNH has been the subject of several other research reports. Cantor Fitzgerald began coverage on shares of UnitedHealth Group in a research note on Monday, February 6th. They issued an “overweight” rating and a $200.00 price target for the company. Vetr raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $179.00 price objective for the company in a research report on Monday. Zacks Investment Research raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $188.00 price objective for the company in a research report on Thursday, March 2nd. Mizuho lifted their price objective on shares of UnitedHealth Group from $178.00 to $200.00 and gave the stock a “buy” rating in a research report on Tuesday, April 18th. Finally, Wells Fargo & Co reaffirmed an “outperform” rating on shares of UnitedHealth Group in a research report on Tuesday, February 21st. Two analysts have rated the stock with a hold rating and twenty-two have given a buy rating to the company’s stock. The company currently has an average rating of “Buy” and an average target price of $182.65.

Earnings History and Estimates for UnitedHealth Group (NYSE:UNH)

COPYRIGHT VIOLATION NOTICE: This report was published by Chaffey Breeze and is the sole property of of Chaffey Breeze. If you are accessing this report on another domain, it was stolen and reposted in violation of U.S. and international copyright and trademark laws. The correct version of this report can be accessed at https://www.chaffeybreeze.com/2017/05/19/unitedhealth-group-inc-unh-forecasted-to-earn-q1-2017-earnings-of-2-19-per-share-updated-updated-updated.html.

Shares of UnitedHealth Group (NYSE:UNH) traded up 0.56% during mid-day trading on Tuesday, hitting $172.41. The stock had a trading volume of 2,435,629 shares. The firm has a market cap of $166.14 billion, a PE ratio of 22.07 and a beta of 0.68. UnitedHealth Group has a 12 month low of $130.01 and a 12 month high of $176.14. The stock’s 50-day moving average is $170.05 and its 200 day moving average is $162.31. UnitedHealth Group also was the target of unusually large options trading activity on Tuesday. Traders bought 490 put options on the stock. This represents an increase of approximately 195% compared to the typical volume of 166 put options.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, April 18th. The healthcare conglomerate reported $2.37 earnings per share for the quarter, topping analysts’ consensus estimates of $2.17 by $0.20. The company had revenue of $48.72 billion during the quarter, compared to analyst estimates of $48.21 billion. UnitedHealth Group had a return on equity of 21.20% and a net margin of 3.92%. UnitedHealth Group’s revenue was up 9.4% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.81 earnings per share.

A number of hedge funds and other institutional investors have recently modified their holdings of the company. Jackson Grant Investment Advisers Inc. raised its position in shares of UnitedHealth Group by 0.4% in the fourth quarter. Jackson Grant Investment Advisers Inc. now owns 1,093 shares of the healthcare conglomerate’s stock valued at $175,000 after buying an additional 4 shares during the last quarter. Biegel & Waller LLC raised its position in shares of UnitedHealth Group by 0.3% in the first quarter. Biegel & Waller LLC now owns 1,234 shares of the healthcare conglomerate’s stock valued at $202,000 after buying an additional 4 shares during the last quarter. Adirondack Trust Co. raised its position in shares of UnitedHealth Group by 0.5% in the first quarter. Adirondack Trust Co. now owns 990 shares of the healthcare conglomerate’s stock valued at $162,000 after buying an additional 5 shares during the last quarter. Beck Mack & Oliver LLC raised its position in shares of UnitedHealth Group by 0.3% in the third quarter. Beck Mack & Oliver LLC now owns 2,708 shares of the healthcare conglomerate’s stock valued at $379,000 after buying an additional 8 shares during the last quarter. Finally, Paradigm Financial Advisors LLC raised its position in shares of UnitedHealth Group by 0.4% in the first quarter. Paradigm Financial Advisors LLC now owns 2,761 shares of the healthcare conglomerate’s stock valued at $452,000 after buying an additional 11 shares during the last quarter. Institutional investors own 86.67% of the company’s stock.

In other UnitedHealth Group news, Director William C. Ballard, Jr. sold 5,000 shares of the company’s stock in a transaction dated Thursday, April 20th. The shares were sold at an average price of $170.47, for a total transaction of $852,350.00. Following the transaction, the director now directly owns 75,735 shares in the company, valued at $12,910,545.45. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Gail R. Wilensky sold 5,310 shares of the company’s stock in a transaction dated Thursday, February 23rd. The stock was sold at an average price of $162.31, for a total transaction of $861,866.10. Following the transaction, the director now owns 60,175 shares in the company, valued at $9,767,004.25. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 40,148 shares of company stock worth $6,806,849. Company insiders own 1.65% of the company’s stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

5 Day Chart for NYSE:UNH

Get a free copy of the Zacks research report on UnitedHealth Group (UNH)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for UnitedHealth Group Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply